Vascular endothelial growth factor signalling is an effective target for cancer treatment, and tumours growth can be effectively inhibited by anti-angiogenic therapy without obvious side effects.20 In the treatment of cervical cancer, the use of oral anti-angiogenic drugs in the treatment of cervical cancer can extend the treatment time to 540 days, and the complication rate in the treatment is low, which has a certain degree of safety.21 This evidence concerns the gene VEGFA and cervical cancer.